Dr. Christopher Brown is a co-founder of 908 Devices and has served on its board since June 2025. Since March 2025 he has been Vice President of R&D Analytics at Repligen, following Repligen's acquisition of 908 Devices' bioprocessing analytics portfolio; he was previously the company's Chief Product Officer and, earlier, Chief Technology Officer and Vice President of Research and Development. He holds a B.Sc. in Mathematics/Chemistry from Brandon University and a Ph.D. in Chemistry from Dalhousie University.